Health and Care Bill

Moved by

Baroness McIntosh of Pickering

78: Clause 20, page 17, line 14, at end insert—

“14Z39A Duty to review latest innovations with a view to local commissioning

(1) Integrated care boards must review all new—

(a) medicines,

(b) medical devices, and

(c) other health care solutions that may benefit the local population.

(2) Integrated care boards must—

(a) appoint a dedicated innovation officer to their board, and

(b) develop and maintain a system to keep up to date with medicines and devices innovation and review suitability for patient usage, including engagement with the relevant—

(i) academic health science network, and

(ii) local pharmaceutical committee.”

Member’s explanatory statement

This amendment would mandate ICBs to monitor and assess innovation for the benefit of the local population.